Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Taisho/Ikeda Mohando describe anti-H. pylori agent

April 9, 1997

Fujisawa reports antiulcer agents

April 9, 1997

5-LO inhibitor not effective as monotherapy in active ulcerative colitis

April 7, 1997

Positive phase III results reported for Centocor's Crohn's disease treatment

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Transdermal nicotine associated with clinical improvement in ulcerative colitis

April 2, 1997

Gilead's GS-840 enters phase II for chronic hepatitis B treatment

April 1, 1997

Extended treatment with Intron A for hepatitis C cleared by FDA

April 1, 1997

Shaman commences phase II trials of Provir in AIDS-related diarrhea

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...